DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence

Molecular Psychiatry

Volumn 18, Issue 4, 2013, Pages 401-402

  Mota, N R ^a   Rovaris, D L ^a   Bertuzzi, G P ^a   Contini, V ^a   Vitola, E S ^a   Grevet, E H ^a   Roman, T ^a   Callegari Jacques, S M ^a   Hutz, M H ^a   Bau, C H D ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR;

ALCOHOLISM; ATTENTION DEFICIT DISORDER; EXON; GENE EXPRESSION; GENE FREQUENCY; GENE INTERACTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; LETTER; MENTAL DISEASE; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

ADULT; ALCOHOLISM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PROTEIN MULTIMERIZATION; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 84884211403     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.50     Document Type: Letter

References (9)

1. Borroto-Escuela DO, Van Craenenbroeck K, Romero-Fernandez W, Guidolin D, Woods AS, Rivera A et al. Biochem Biophys Res Commun 2011; 404: 928-934.
2. Gonzalez S, Rangel-Barajas C, Peper M, Lorenzo R, Moreno E, Ciruela F et al. Mol Psychiatry advance online publication, 16 August 2011; doi:10.1038/mp.2011.93 (e-pub ahead of print).
3. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R et al. Proc Natl Acad Sci USA 2007; 104: 20552-20557.
4. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, Mash DC et al. Neuropsychopharmacology 2011; 36: 753-762.
5. Roman T, Bau CHD, Almeida S, Hutz MH. Addict Biol 1999; 4: 203-207.
6. Bau CHD, Almeida S, Hutz MH. Am J Med Genet 2000; 96: 302-306.
7. Grevet EH, Bau CHD, Salgado CA, Fischer AG, Kalil K, Victor MM et al. Eur Arch Psychiatry Clin Neurosci 2006; 256: 311-319.
8. Hosmer D, Lemeshow S. Wiley-Interscience Publication: New York, USA, 2000.
9. Krystal JH, Petrakis IL, Mason G, Trevisan L, D'Souza DC. Pharmacol Ther 2003; 99: 79-94.